SKI Market

A+| A| A-|

Indian Indices

Sensex

73,583.22 -1,690.23
( -2.25%)

Global Indices

Nasdaq

45,986.51 -463.99
(-1.00%)

Dow Jones

6,496.71 -116.19
(-1.76%)

Hang Seng

53,412.46 -191.19
(-0.36%)

Nikkei 225

9,959.27 -12.90
(-0.13%)

Forex

USD-INR

93.86 0.07
(0.08%)

EUR-INR

108.76 0.06
(0.06%)

GBP-INR

125.66 0.01
(0.01%)

JPY-INR

0.59 0.00
(-0.13%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Medicamen Organics Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

92885

INE0PE401018

24.7648718

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

MEDIORG

7.88

25.8

EPS(TTM)

Face Value()

Div & Yield %

2.8

Back

Indo Rama Synthetics (India) reports consolidated net profit of Rs 24.55 crore in the September 2025 quarter

Nov 11,2025

Net profit of Indo Rama Synthetics (India) reported to Rs 24.55 crore in the quarter ended September 2025 as against net loss of Rs 44.08 crore during the previous quarter ended September 2024. Sales rose 28.42% to Rs 1220.64 crore in the quarter ended September 2025 as against Rs 950.53 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	1220.64	950.53	28
OPM %	5.60	0.32	-
PBDT	36.53	-32.35	LP
PBT	24.55	-44.08	LP
NP	24.55	-44.08	LP

73,583.22 -1,690.23 ( -2.25%)

45,986.51 -463.99 (-1.00%)

6,496.71 -116.19 (-1.76%)

53,412.46 -191.19 (-0.36%)

9,959.27 -12.90 (-0.13%)

93.86 0.07 (0.08%)

108.76 0.06 (0.06%)

125.66 0.01 (0.01%)

0.59 0.00 (-0.13%)